The Danger Zone

Years ago before Animas was bought by JNJ the company seemed to be doing well but behind the scenes was a much different story. In a somewhat famous moment for Diabetic Investor while attending the J P Morgan conference we overheard the then CEO state she was looking to sell the company. A comment we reported, she denied and then the company was sold.

After JNJ paid over $500 million for the company, which happened right before Animas was supposed to report earnings, we learned that JNJ had no choice but to buy the company as it was on the . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.